Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioLineRx ADS Representing 15 Ord Shs BLRX

Healthcare Biotechnology
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform ,... see more

NDAQ:BLRX - Post Discussion

BioLineRx ADS Representing 15 Ord Shs > Today 93 cents ..... Target Price $3.50 276% upside!
View:
Post by aebestacey on Jul 19, 2017 7:27pm

Today 93 cents ..... Target Price $3.50 276% upside!

Analysts Covering BiolinerxAnalyst Ratings

Analyst Consensus

Moderate Buy

Based on 2Analyst Ratings

  • 2Buy
  • 0Hold
  • 0Sell

Based on 2Wall Streetanalysts offering recommendations for BLRXin the last 3 months (by analysts

Analyst Price Target on BLRX

Average Price Target

$3.50

(276.34%Upside)

Based on 2analystsoffering 12 month price targets for BLRXin the last 3 months. The average price target is $3.50with a high estimate of $4.00and a low estimate of $3.00.

Past
12 Months    Next
12 MonthsJul2016OctJan2017AprJul$0$1.23$2.48$3.73$5Jul2018
 
Average
$3.50
Low
$3.00
High
$4.00

Filters

 

 

 
Be the first to comment on this post
BioLineRx ADS Representing 15 Ord Shs
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities